Derchansky Profile.jpeg

"As a former Corporate VC and Pharma VP,  I founded Blackletter to help senior pharma executives get exposure to real and actionable digital innovations and successfully bring them into the 'core' pharma business. My team of 20 consultants helps you navigate the challenge of showing the rest of the organization the tangible business impact of digital without the hype. It's not easy, but with patience, grit and a creative and entrepreneurial drive, it can be done."

Miron Derchansky (MBA, PhD)
Founder and Managing Director, Blackletter Group

Innovative Pharma Clients Served

Digital Investment Cases Made

Pilots and Co-Development Projects Launched

Technologies Scouted

Internal Software Products Launched

Our Guiding Principles


Problems first. Technology Second

Whether our clients have a detailed 'Wish List' of science and technology, we first focus on what problem they are solving as innovation can come from the most unexpected places and being too close to the tree risks missing the forest.


momentum is our oxygen

Working in some of the world's most dynamic and competitive innovation ecosystems, we know that identifying and validating opportunities quickly brings our clients the edge their competitors lack.


curiosity and experimentation win

Our clients are the world's leading life sciences companies looking for solutions to some of their most intractable problems - having an experimentation and co-creation mindset on every project is how we uncover unique solutions.


quality is king

While innovation is part art and part science, our management consulting and venture capital roots drive a relentless focus on superior analysis and comprehensive research so that our clients are empowered to make the most impactful decisions.